Aperio Group, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2020$52,000
+79.3%
18,8100.0%0.00%
Q3 2020$29,000
-17.1%
18,8100.0%0.00%
Q2 2020$35,000
+29.6%
18,810
+20.6%
0.00%
Q1 2020$27,000
-40.0%
15,5960.0%0.00%
Q4 2019$45,000
+246.2%
15,596
-24.6%
0.00%
Q3 2019$13,000
-43.5%
20,687
-11.8%
0.00%
Q2 2019$23,000
+53.3%
23,442
+117.1%
0.00%
Q1 2019$15,00010,7970.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders